Britain launches the West's first mass coronavirus vaccination

In England, a 90-year-old grandmother named Maggie Keenan and an 81-year-old man named William Shakespeare have become the first and second non-trial recipients of Pfizer's COVID-19 vaccine.

In England, a 90-year-old grandmother named Maggie Keenan and an 81-year-old man named William Shakespeare have become the first and second non-trial recipients of Pfizer's COVID-19 vaccine. The administrations, which kicked off the first mass coronavirus immunization campaign in the West, are hoped to turn around a public health crisis responsible for more than 1.54 million deaths worldwide. With priority given to older adults and nursing home caregivers, British officials aim to vaccinate most vulnerable populations by the end of February—provided there is enough supply to do so. Britain has 40 million doses on preorder of the vaccine developed by Pfizer and its German partner, BioNTech, but is receiving only 800,000 doses initially. While it also has another 300 million doses on reserve with the manufacturers of five other vaccine candidates, only Pfizer has won regulatory approval so far. The company also could receive emergency authorization in the United States as soon as this week and in the European Union by the end of this year.